ARCA BIOPHARMA INC

NASDAQ

ABIO

tradingbulls2

Looks like going double digit soon

UnderwearTrader

looks ready to go again even higher

Lanmar

The company is a very small market cap so it's considerably higher risk than most stocks. Stocks like these require very small positions.

gamer456148

First off, please don't take anything I say as financial advice and as always everything is on an opinion based basis. Pursue your own due diligence. That being said, ABIO seems to have a decent setup for potentially another bull run quite soon. The resistance curve is about to pop and it looks like this is a close watch as with other stocks I been watching. In my...

Alexey_Malorodov

NASDAQ:ABIO Another possible short for today. After a sharp rise on May 28, the paper could not grow any further. All the growth has already been sold. At 6.81 instrument faced a strong support level. Within 3 days there were a level tests. On June 22, the big long player managed to raise the price slightly from 6.89 to 7.52. However, in the last trading...

meslamipour

ABIO LONG

keifer

Hello, What is ABIO? ARCA biopharma, Inc. (ARCA) is a biopharmaceutical company. The Company is principally focused on developing genetically-targeted therapies for cardiovascular diseases. The Company's lead product candidate is Gencaro (bucindolol hydrochloride), a beta-blocker and mild vasodilator that the Company is evaluating in a clinical trial for the...

Stockwizard23

ABIO Long or short will see first thing in the morning.

AlenCiken

ARCA BIOPHARMA ANNOUNCES AB201 DEVELOPMENT PROGRAM FOR TREATMENT OF COVID-19 ASSOCIATED COAGULOPATHY arcabio.com The Westminster, Colorado-based company said it plans to evaluate AB201, a selective inhibitor of tissue factor, as a potential treatment for...

tradingXp

2

Avih

ABIO Sell Potential

WaveAzzReaderz

Upon Request backtest only. I don't trade usually trade penny craps because most of them are a pump and dump scheme. Might take down this "unethical investment" sooner or later.

PennyStock101

Be on the watch-out for massive continuation today after great results yesterday. Already up 19% premarket. RESULTS TRANSCRIPT “In the first part of this year, we continued to make progress on our lead development program Gencaro, achieving an agreement with the FDA on our Special Protocol Assessment for the PRECISION-AF Phase 3 clinical trial evaluating Gencaro...

dobisa

Maybe it's too early to tell but I like it

TheTradersBias

Nice moves

AlenCiken

today announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) on the design of a pivotal Phase 3 clinical trial, PRECISION-AF, to assess the safety and efficacy of GencaroTM (bucindolol hydrochloride) as a genetically-targeted treatment for atrial fibrillation (AF) in patients with a...

TradeWithTyler

Biggest gapper today #ABIO $ABIO, fell right away at market open. Looks to be setting up some possible support, ill watch it tomorrow and the next few days to see if we can break back above the median. You can visit my youtube and watch my full video recap, link in the description!

SwingBatter12

Target 1 .48 Target 2 .6